Production (Stage)
CVS Health Corporation
CVS
$60.83
$0.611.01%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.92% | 3.65% | 6.02% | 2.47% | 3.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.92% | 3.65% | 6.02% | 2.47% | 3.58% |
| Cost of Revenue | 5.69% | 6.10% | 8.77% | 3.36% | 5.53% |
| Gross Profit | 14.61% | -10.76% | -9.71% | -2.55% | -7.16% |
| SG&A Expenses | 4.48% | 0.76% | 7.50% | 5.47% | 6.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.55% | 5.49% | 8.63% | 3.60% | 5.61% |
| Operating Income | 66.51% | -44.82% | -57.59% | -24.03% | -43.58% |
| Income Before Tax | 65.63% | -21.40% | -96.52% | -9.07% | -45.12% |
| Income Tax Expenses | 83.11% | -23.56% | -95.49% | -13.26% | -38.13% |
| Earnings from Continuing Operations | 58.54% | -20.71% | -96.87% | -7.63% | -47.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 72.73% | 2,200.00% | 500.00% | 115.38% | -83.33% |
| Net Income | 59.84% | -19.65% | -96.15% | -6.89% | -47.89% |
| EBIT | 66.51% | -44.82% | -57.59% | -24.03% | -43.58% |
| EBITDA | 42.73% | -33.42% | -42.88% | -17.43% | -30.85% |
| EPS Basic | 59.72% | -17.80% | -96.07% | -4.89% | -46.94% |
| Normalized Basic EPS | 76.94% | -35.73% | -56.04% | -22.36% | -46.22% |
| EPS Diluted | 60.23% | -17.80% | -96.05% | -4.78% | -46.67% |
| Normalized Diluted EPS | 77.52% | -35.58% | -55.94% | -22.30% | -46.19% |
| Average Basic Shares Outstanding | 0.08% | -2.25% | -2.18% | -2.10% | -1.79% |
| Average Diluted Shares Outstanding | -0.24% | -2.47% | -2.40% | -2.18% | -1.86% |
| Dividend Per Share | 0.00% | 9.92% | 9.92% | 9.92% | 9.92% |
| Payout Ratio | -0.37% | 0.34% | 26.92% | 0.16% | 1.07% |